Living fossils not so fossilized; Canadian gov’t threatens scientists’ freedom to speak and publish; gene therapy for sensory disorders; an unusual theory of cancer; clues for an HIV vaccine
Living fossils not so fossilized; Canadian gov’t threatens scientists’ freedom to speak and publish; gene therapy for sensory disorders; an unusual theory of cancer; clues for an HIV vaccine
Researchers develop two small molecules that slow the growth of human cancer cells.
Researchers track the evolution of HIV in a single patient to understand what drives the production of broadly neutralizing antibodies.
Advances in genomics and cancer biology will alter the design of human cancer studies.
| April 1, 2013
Meet some of the people featured in the April 2013 issue of The Scientist.
A decade into the age of genomics, science is generating a flood of data that will help in the quest to eradicate the disease.
Scientists develop a gel that mimics mollusc glue to coat the insides of blood vessels.
By scrutinizing gene expression profiles instead of individual oncogenes, Todd Golub launched a powerful platform for diagnosing, classifying, and treating cancer.
Research into how the brain suffers as a result of chemotherapy is revealing potential avenues for ameliorating cognitive decline.
Scientists are using genetic techniques to target diseases that affect how we see, hear, smell, taste, and feel.